Fusion of HMGA2 to COG5 in uterine leiomyoma

Gopalrao V.N. Velagaleti, Vijay S. Tonk, Nawar M. Hakim, Xiaoke Wang, Hongying Zhang, Michele R. Erickson-Johnson, Fabiola Medeiros, Andre M. Oliveira

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


Uterine leiomyomas are smooth muscle tumors most commonly seen in middle-aged women. Approximately 10% of these tumors contain rearrangements of the chromatin-remodeling gene HMGA2 at the chromosome band 12q14.3. Herein, we report on a uterine leiomyoma with a novel HMGA2 fusion gene. A 44-year-old woman presented with a 20-cm mass uterine leiomyoma. From a histological standpoint, the tumor exhibited extensive hyalinization, very low mitotic activity (<1/10 HPH), and no cytologic atypia. Smooth muscle differentiation was confirmed by the expression of smooth muscle actin and desmin. Standard cytogenetic analysis showed the reciprocal translocation t(7;12)(q31.2;q14.3). Fluorescence in situ hybridization analysis confirmed a balanced rearrangement of the HMGA2 locus in 80% of the cells. 3'RACE reverse-transcription polymerase chain reaction identified the fusion of HMGA2 exon 4 to the COG5 locus on 7q31 (component of oligomeric golgi complex 5 isoform). The fusion sequence is predicted to encode a 96-amino acid chimeric protein that retains all three DNA-binding domains (AT hooks) of HMGA2, but that is shorter than the original HMGA2 protein. Since the general structure of the fusion gene is similar to other previously described HMGA2 fusions, its biologic activity is predicted to be likely similar.

Original languageEnglish (US)
Pages (from-to)11-16
Number of pages6
JournalCancer Genetics and Cytogenetics
Issue number1
StatePublished - Oct 2010
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research


Dive into the research topics of 'Fusion of HMGA2 to COG5 in uterine leiomyoma'. Together they form a unique fingerprint.

Cite this